BRIEF: MedBot reports strong year-to-date sales as commercialization accelerates
Shanghai MicroPort MedBot (Group) Co. Ltd. (2252.HK) said on Wednesday that cumulative orders for its core products, including laparoscopic, orthopedic, and vascular intervention surgical robots, surpassed 170 units as of…
BRIEF: MicroPort MedBot raises $35 million in share placement at 20% discount
Surgical robot developer Shanghai MicroPort MedBot (Group) Co. Ltd. (2252.HK) on Tuesday announced it placed 34.7 million new shares, or about 3.45% of its enlarged share capital, at a price of HK$7.85 per…
FAST NEWS: MicroPort MedBot places shares at significant discount
The Latest: Shanghai MicroPort MedBot (Group) Co. Ltd. (2252.HK) on Thursday announced it placed 12.9 million new shares at a price of HK$9.10 per share, raising approximately HK$117 million ($15…
MedBot seeks commercial edge with dual-use surgical robot
The company’s orthopedic robot is the first domestically developed device to be approved for both hip and knee surgeries Key Takeaways: Even with its latest product, MicroPort MedBot faces intensifying…
Charged by Surgical Robot’s Approval, Shenzhen Edge Medical Makes New IPO Bid
The medical device maker filed a second time for a Hong Kong IPO after updating its prospectus with the recent approval of its first surgical robotKey Takeaways:Shenzhen Edge Medical got…
Recent Articles
RELATED ARTICLES
-
BRIEF: MicroPort ‘s revenue soars in first half of 2025
2252.HK
-
Feihe’s sliding profits point to China dairy market past its sell-by date
6186.HK
-
BRIEF: EHang reports wider loss, slashes 2025 revenue guidance
EH.US
-
BRIEF: TCL reports strong first-quarter growth on popularity of large TVs
1070.HK
-
BRIEF: Meitu reports strong profit growth in first half of 2025
1357.HK
- China’s robotaxi commercialization faces hidden barriers
-
Tuya accelerates AI strategy with 93% of shipped products featuring full AI integration
TUYA.US 2391.HK
